Skip to content

The Impact of Opioid-Sparing Strategies on Postoperative Nausea and Vomiting in Women Undergoing Laparoscopic Cholecystectomy

The Impact of Opioid-Sparing Strategies on Postoperative Nausea and Vomiting in Women Undergoing Laparoscopic Cholecystectomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120407
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-16
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting

Interventions

Opioid group:Administer sufentanil 0.4ug/kg during anesthesia induction
Less Opioid Group:Administer sufentanil 0.2ug/kg+ketamine 0.2mg/kg during anesthesia induction
No opioid group:Administer 0.4mg/kg ketamine during anesthesia induction

Sponsors

Taizhou Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Selection criteria 1. ASA classification: I-II level; 2. Age: 20-65 years old; 3.BMI:18-25kg/m^2 4. Non smoking female patients who require laparoscopic cholecystectomy 5. The patient and their family members are fully aware of and voluntarily cooperate with the anesthesia plan and study participation requirements for this examination.

Exclusion criteria

Exclusion criteria: Exclusion criteria Allergy to ketamine; History of severe PONV; Pregnancy or lactation period; Neurological disorders; Long term use of sedatives or hypnotics; Patients with moderate to severe hypertension and/or significantly elevated blood pressure will pose a serious risk; Refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
The incidence and severity of postoperative nausea and vomiting;

Secondary

MeasureTime frame
Vital signs at different time points during surgery;Operation time;Extubation time;First anal exhaust time;The highest postoperative pain score;adverse reaction;Recovery quality within 24 hours after surgery;

Countries

China

Contacts

Public ContactXinghuo Fu

Taizhou Fourth People's Hospital

15052402579@163.com+86 150 5240 2579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026